Skip to main content
. 2014 Apr;88(7):3850–3860. doi: 10.1128/JVI.03456-13

FIG 5.

FIG 5

Antiviral activity of mutant mA3s. ΔVif HIV-1 (a) or MLV (b) carrying luciferase vectors were produced and assayed as described in Materials and Methods. Infectivities (as measured by the ability to induce luciferase in 293-MCAT cells) were normalized to RT activities, and this ratio for the controls lacking mA3 was set at 100%. Results are presented as relative specific (Rel. Sp.) infectivities. Error bars represent standard deviations.